Company intelligence / Profile preview

Level Biotechnology

Hsi-Chih, New Taipei City, Taiwan

Ownership: Private
Development stage: Other

Overview

Level Biotechnology provides comprehensive preclinical CRO services including regulatory toxicology, genetic toxicology, pharmacology, biocompatibility studies, and model animal production. The company has ISO9001 certification and AAALAC-accredited animal facilities. It does not have its own clinical pipeline but supports the development of new chemical entities and medical devices for clients in biotech/pharma/medical device sectors.

Modalities: Small moleculeMedical deviceAntibody reagents
Industry: Contract Research Organization

Partnerships

Academia Sinica technology transfer partnerNational Institutes of Health technology transfer partnerAnimal Center of National Taiwan University collaboration on transgenic mice/raw materials in mice market

Beyond the preview

Go deeper on Level Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Level Biotechnology.

Explore the full profile